Apixaban Dosing for Venous Thromboembolism in Patients with Impaired Renal Function

Standard VTE Dosing for Apixaban

• The American College of Cardiology recommends initial treatment with apixaban at 10 mg orally twice daily for the first 7 days, followed by maintenance treatment at 5 mg orally twice daily 2
• For extended treatment after 6 months of initial therapy, the American College of Cardiology suggests either continuing 5 mg twice daily or reducing to 2.5 mg twice daily 2, 3

Renal Function-Based Dosing Recommendations

• The American College of Cardiology states that no dose adjustment is required for patients with mild to moderate renal impairment (CrCl ≥15 mL/min) 1
• Apixaban has a more favorable profile in renal impairment due to its lower renal clearance, with approximately 27% renal elimination 1

Evidence Supporting These Recommendations

• Routine laboratory monitoring is not required for apixaban, as it provides predictable anticoagulation at fixed doses, according to Praxis Medical Insights 4

Clinical Pitfalls to Avoid

• The American College of Cardiology advises against confusing VTE dosing with atrial fibrillation dosing, which has different criteria for dose reduction 2